Diagnostic accuracy of serum Ca 19-9 in predicting malignancy in patients undergoing pancreatic resection.

被引：0
|
作者：
Bekaii-Saab, TS [1 ]
Cowgill, SM [1 ]
Burak, WE [1 ]
Melvin, WS [1 ]
Ellison, EC [1 ]
Muscarella, P [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4210
引用
收藏
页码：365S / 365S
页数：1
相关论文
共 50 条
  • [41] Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancer
    Ohara, K
    Tatsuzaki, H
    Molotkova, NG
    Oda, T
    Yuzawa, K
    Saida, Y
    Matsuzaki, Y
    Shimizu, W
    Todoroki, T
    Fukao, K
    Tanaka, N
    Itai, Y
    HEPATO-GASTROENTEROLOGY, 2001, 48 (39) : 859 - 863
  • [42] Limited Value of CA 19-9 in Predicting Early Treatment Failure in Patients with Advanced Pancreatic Cancer
    Vormittag, Laurenz
    Gleiss, Andreas
    Scheithauer, Werner
    Lang, Fritz
    Laengle, Friedrich
    Kornek, Gabriela V.
    ONCOLOGY, 2009, 77 (02) : 140 - 146
  • [43] SERUM CA 19-9 AND CA 50 ANTIGENS IN HEMODIALYSIS-PATIENTS
    DOCCI, D
    PISTOCCHI, E
    TURCI, F
    BALDRATI, L
    URBINI, S
    SCAIOLI, S
    CLINICAL NEPHROLOGY, 1987, 27 (04) : 179 - 181
  • [44] The diagnostic value of CA 19-9 in patients with pancreatic cancer and none specific GI-symptoms.
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    GASTROENTEROLOGY, 1996, 110 (04) : A1415 - A1415
  • [45] UTILITY OF CA 19-9 IN SERUM AND PANCREATIC-SECRETION IN THE DIAGNOSIS OF PANCREATIC-CARCINOMA
    FORSMARK, CE
    ALBERT, CA
    LAMBIASE, L
    VOGEL, SB
    TORRES, GM
    SUMMERLIN, BJ
    TOSKES, PP
    GASTROENTEROLOGY, 1993, 104 (04) : A304 - A304
  • [46] SERUM AND PANCREATIC-JUICE CA 19-9 DETERMINATION IN PANCREATIC-CANCER DIAGNOSIS
    TOMMASINI, MA
    BOCCHIA, P
    MARCHI, R
    DICARLO, V
    BERETTA, E
    BERSANI, M
    MALESCI, A
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1985, 17 (03): : 171 - 172
  • [47] CA 19-9 Nonproduction Is Associated With Poor Survival After Resection of Pancreatic Adenocarcinoma
    Hayman, Amanda V.
    Stocker, Susan J.
    Baker, Marshall S.
    Bentrem, David J.
    Prinz, Richard A.
    Marsh, Robert de W.
    Talamonti, Mark S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (06): : 550 - 554
  • [48] Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9
    Lundin, J
    Roberts, PJ
    Kuusela, P
    Haglund, C
    ANTICANCER RESEARCH, 1995, 15 (5B) : 2181 - 2186
  • [49] Increased serum carcinomic antigen 19-9(CA 19-9) in a dermoid cyst
    Nanayakkara, S.
    Ali, S.
    Gilmour, K.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 27 (01) : 96 - 97
  • [50] SERUM CA 19-9 CONCENTRATIONS AND COMPUTED-TOMOGRAPHY FINDINGS IN PATIENTS WITH PANCREATIC-CARCINOMA
    SAKAHARA, H
    ENDO, K
    NAKAJIMA, K
    NAKASHIMA, T
    KOIZUMI, M
    OHTA, H
    HIDAKA, A
    KOHNO, S
    NAKANO, Y
    NAITO, A
    SUZUKI, T
    TORIZUKA, K
    CANCER, 1986, 57 (07) : 1324 - 1326
12345